This site is password-protected.

Incorrect password. Please try again.

Problem Solution Team Investors Contact

BiSafe Biologics

Naturally safeguarding your herd.

Scroll

A Virus Epidemic
Killing Animals

Rapid Spread

Bluetongue virus is quickly spreading across Europe and beyond, transmitted by biting midges (Culicoides).

Devastating Mortality

Mortality rates up to 73% in sheep, causing enormous economic losses for farmers across the continent.

No Effective Solution

Current vaccines are minimally effective, and insecticides are expensive, harmful, and not targeted.

Probiotic
Midge Repellent

BiSafe harnesses naturally occurring skin bacteria to repel biting midges — providing herd-level protection against all midge-borne diseases.

Biting Reduction

Scientifically validated: selection of sheep skin bacteria significantly reduces Culicoides midge biting.

Brok et al (2024) — Selection of sheep skin bacteria to reduce biting by Culicoides midges

Complete Prevention

By repelling midges, BiSafe prevents transmission of all midge-borne diseases — not just Bluetongue.

Herd-Level Protection

One application protects the entire herd, creating a collective defense shield for your livestock.

Why BiSafe wins

BiSafe Vaccines Insecticides
Efficacy High ~ Moderate Low
Cost $ $$$ $$
Env. Impact None ~ Low High
Easy Application Yes No ~ Moderate

Easy Application

Simple spray-on application — no veterinary expertise required.

Environmentally Friendly

100% natural, probiotic-based — zero chemicals, zero environmental harm.

Non-Toxic

Safe for animals, humans, and the environment — no harmful residues.

Scalable &
Cost-Effective

CHF 40 for 20L of BiSafe
  • Treats 1,000 sheep for 1 week
  • Or 500 cattle for 1 week
  • CHF 1.20 per sheep per year
  • CHF 2.40 per cattle per year

Licence Plans

Starter

1 Month

CHF 40/unit

  • Short-term protection
  • Ideal for outbreak response
  • 2 applications included
  • Standard support
Get Started
Full Season

Whole Season

CHF 180/unit

Save 25%

  • April – October coverage
  • Complete peace of mind
  • 14 applications included
  • Dedicated account manager
Get Started

Path to
Launch

2024 Q4

🏆 Startup Campus Award

Class Winner 2024 (UZH I) — Innosuisse Business Concept, awarded December 2024.

2025 Q1

Confirmed Research

Validated core probiotic repellent through confirmed scientific research.

2025 Q4

Prototype Testing

Field testing on livestock to validate efficacy under real-world conditions.

2026 Q1

Authorization

Regulatory authorization process for market entry.

2026 Q2

UZH Innovation Grant

Accepted in the UZH Innovation Grant Program.

2026 Q3

Patent Application

Patent application.

2026 Q4

PhD Publication

PhD publication.

2027 Q1

Product Launch

Commercial launch of BiSafe across DACH region and EU markets.

The People Behind
BiSafe

Alec Hochstrasser

Alec Hochstrasser

CEO / Biologist PhD (in process)

Leading BiSafe's scientific vision and product development with deep expertise in biology and microbiology.

Irene Seebacher

Irene Seebacher

Finance & Operations MSc Business & Development

Background in Strategy Consulting, Finance & Operations in both large Tech companies and Startups.

Isaac Meier

Isaac Meier

Corporate Law LL.M. (Berkeley)

Experience and background in Intellectual Property, Venture Capital and Corporate Law and Finance.

Luca Scognamiglio

Luca Scognamiglio

IP Law & Business Development MLaw

Experience in project management and leading a Swiss association. Expertise in IP law and business development.

Get in Touch

Have a question or want to collaborate? Drop us a message.

Investor Area

Please sign in with your username and password.

Incorrect username or password. Please try again.

Investor Overview

Protected content

Investor materials are locked

Unlock the investor area to load the protected investor materials.